Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nomura, A. M. Y.
Right arrow Articles by Pollak, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nomura, A. M. Y.
Right arrow Articles by Pollak, M. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2003; 158:424-431.
Copyright © 2003 by Johns Hopkins Bloomberg School of Public Health


ORIGINAL CONTRIBUTIONS

Serum Insulin-like Growth Factor I and Subsequent Risk of Colorectal Cancer among Japanese-American Men

Abraham M. Y. Nomura1 , Grant N. Stemmermann2, James Lee1 and Michael N. Pollak3

1 Japan-Hawaii Cancer Study, Kuakini Medical Center, Honolulu, HI.
2 Department of Pathology, University of Cincinnati Medical Center, Cincinnati, OH.
3 Cancer Prevention Research Unit, Departments of Medicine and Oncology, Jewish General Hospital and McGill University, Montreal, Quebec, Canada.

Recent reports suggest that colorectal cancer is positively related to insulin-like growth factor I (IGF-I) and inversely related to insulin-like growth factor binding protein 3 (IGFBP-3). To evaluate these associations further and separately for colon and rectal cancer, the authors conducted a nested case-control study in a cohort of 9,345 Japanese-American men examined in Hawaii in 1971–1977. A total of 177 incident colon cancer cases and 105 incident rectal cancer cases were identified from 1972 to 1996. These patients’ stored sera and those of 282 age-matched controls were measured for IGF-I and IGFBP-3. The adjusted mean level of IGF-I was higher in colon cancer cases than in controls (154.7 ng/ml vs. 144.4 ng/ml; p = 0.01). However, the multivariate odds ratio for the highest quartile compared with the lowest was just 1.8 (95% confidence interval: 0.8, 4.3). Adjusted mean IGF-I levels were similar between rectal cancer cases and their controls. For IGFBP-3, adjusted mean levels were lower for both colon and rectal cancer cases than for their matched controls, but the differences were not significant. The IGF-I results weakly support findings from other studies and suggest that there are differences in IGF-I findings between colon and rectal cancer cases. It is possible that IGF-related risk is confounded by other factors that may vary among different cohorts. Further research is needed to clarify these relations.

colonic neoplasms; colorectal neoplasms; insulin-like growth factor I; insulin-like growth factor binding protein 3; rectal neoplasms

Abbreviations: Abbreviations: IGF, insulin-like growth factor; IGFBP, insulin-like growth factor binding protein.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Flood, V. Mai, R. Pfeiffer, L. Kahle, C. J. Rosen, E. Lanza, and A. Schatzkin
Serum Concentrations of Insulin-Like Growth Factor and Insulin-Like Growth Factor Binding Protein 3 and Recurrent Colorectal Adenomas
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1493 - 1498.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. T. Jacobs, M. E. Martinez, D. S. Alberts, E. L. Ashbeck, S. M. Gapstur, P. Lance, and P. A. Thompson
Plasma Insulin-Like Growth Factor I Is Inversely Associated with Colorectal Adenoma Recurrence: A Novel Hypothesis
Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 300 - 305.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Schaffer, A. Koushik, H. Trottier, E. Duarte-Franco, N. Mansour, J. Arseneau, D. Provencher, L. Gilbert, W. Gotlieb, A. Ferenczy, et al.
Insulin-like Growth Factor-I and Risk of High-Grade Cervical Intraepithelial Neoplasia
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 716 - 722.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A M M Haydon, R J MacInnis, D R English, H Morris, and G G Giles
Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer
Gut, May 1, 2006; 55(5): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter
Insulin-like Growth Factor Polymorphisms and Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1204 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. W. Voskuil, A. Vrieling, L. J. van't Veer, E. Kampman, and M. A. Rookus
The Insulin-like Growth Factor System in Cancer Prevention: Potential of Dietary Intervention Strategies
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 195 - 203.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.